Roflumilast 70771-1673-08

Package NDC

70771-1673-08

Manufacturer: Zydus Lifesciences Limited
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 18, 2023
Listing Expires: December 31, 2026
Application: ANDA208303

Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Roflumilast	250 ug/1

Drug Class

Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]

Selected Package

70771-1673-08Selected

1 BLISTER PACK in 1 CARTON (70771-1673-8) / 28 TABLET in 1 BLISTER PACK

Other packages for this product(1)

70771-1673-03

2 BLISTER PACK in 1 CARTON (70771-1673-3) / 10 TABLET in 1 BLISTER PACK (70771-1673-2)

View →